key: cord-0781352-gibs74g3
authors: Kho, Jason; Mandal, Amit K. J.; Geraldes, Ruth; Tuzlali, Hatice; Boyd, Elena; Nortley, Ross; Missouris, Constantinos G.
title: COVID‐19 encephalitis and Wernicke's encephalopathy
date: 2021-05-24
journal: J Med Virol
DOI: 10.1002/jmv.27088
sha: 87d141baa733137cf844d119523661e3bf0c0ba5
doc_id: 781352
cord_uid: gibs74g3

nan

To The Editor, Patients with COVID-19 can present with acute encephalopathy and changes in the level of consciousness. A 74-year-old high-functioning woman was admitted after two brief syncopal episodes with eyerolling. In addition, she reported a dry cough for 6 weeks without associated symptoms. There was no relevant past medical history and she did not drink alcohol.

Clinical examination revealed bibasal crackles on chest auscultation and oxygen desaturation on mild exertion. Glasgow Coma Scale (GCS) score was 15/15 and neurological assessment was normal. Investigations were notable for lymphocyte count of 0.51 × 10 9 /L Although vomiting and nutritional insufficiency were key to the development of WE and dry beriberi in our patient, active COVID-19 may have contributed to the demyelinating process. Multiple mechanisms of neuronal injury by coronaviruses have been described; these include hypoxia and immune-mediated injury. 6 We postulate that the combination of these mechanisms and viral invasion of glial cells may lead to significant neuroinflammation and subsequent blood-brain barrier (BBB) breakdown. This is likely mediated by ACE2-viral binding with either direct BBB entry through invasion of glial cells or indirect entry via infiltration of BBB endothelial cells (ACE2 being abundant in both cell types). These processes are thought to be mirrored in the PNS with resultant inflammation and demyelination.

We lay emphasis upon thorough neurological assessment and prompt neuroimaging for COVID-19 patients who present with confusion and altered mental status. We highlight the inherent risks of malnutrition and metabolic encephalopathy among COVID-19 patients with protracted vomiting or prolonged illness.

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)

Guillain-Barré syndrome associated with SARS-CoV-2

Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy

Dry beriberi due to thiamine deficiency associated with peripheral neuropathy and Wernicke's encephalopathy mimicking Guillain-Barrè syndrome: a case report and review of the literature

Primary cultures of rat astrocytes respond to thiamine deficiency-induced swelling by downregulating aquaporin-4 levels

Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review

The authors declare that there are no conflict of interests. F I G U R E 1 Area postrema hyperintensities on T2-weighed axial (A) and sagittal fluid-attenuated inversion recovery (FLAIR) imaging (B), midbrain tectal hyperintensities on both sagittal and axial FLAIR imaging (B and C) and on the bilateral medial thalami, around the third ventricle, on axial T2W images (D) were seen 21 days after first COVID-19 diagnosis. Five days later a repeat brain magnetic resonance imaging scan with contrast showed partial resolution of the area postrema T2 hyperintensities, as seen in axial T2W images (E) and sagittal FLAIR images (F) but with mild contrast enhancement in this area on axial T1 weighted imaging (I). T2 and FLAIR hyperintensities were less evident in the midbrain tectal plate (G) and medial thalami (H), respectively. However, there was significant contrast enhancement of these areas (J-L) as well as bilateral mamillary bodies (K). After treatment, 38 days post-COVID-19 diagnosis, all the previously described signal abnormalities regressed (M, N, and P) except for mild T2 hyperintensity of the tectal plate. (N and O) The contrast enhancement of the previously affected areas regressed (Q-T) with the mild persisting enhancement of the tectal plate (R) and mamillary bodies (S)